פתיחת מחסום הדם-מוח כסמן ביולוגי לאלצהיימר: מחקר בדימות מגנטי

Investigation of the applicability of an MRI based blood-brain barrier disruption assessment as a pre-symptomatic biomarker for Alzheimer's disease: a proof of concept study

Contact Person:

Dr. Itzik Cooper

PI: Dr. Ramit Ravona-Springer

 Approving Institute:

Sheba Medical Center

Research Description:

Investigation of the applicability of an MRI based blood-brain barrier disruption assessment as a pre-symptomatic biomarker for Alzheimer's disease: a proof of concept study.